Samsung Biologics, a global contract development and manufacturing organization (CDMO), and Kurma Partners, a European venture capital firm in healthcare and...

The 7th edition of the CPHI Annual Survey was unveiled today highlighting trends for 2024. A total of 250 pharmaceutical executives were surveyed with 35 probing...

The US pharmaceutical company Pfizer has been cleared to acquire Seagen, a biotech company focused on developing cancer treatments.

At its Capital Markets Day in Visp, Switzerland, Lonza shared a detailed update on its strategic priorities and provided new Mid-Term Guidance for 2024 to 2028.

Amgen has completed its acquisition of Horizon Therapeutics for approximately $27.8 billion. The acquisition was approved by the US Federal Trade Commission (FTC) in...

Olon Biotech, a division of Italian API producer Olon, has inaugurated a new facility for the industrial-scale production of proteins from alternative sources at its site...

Pierre-Alain Ruffieux, CEO of Lonza, will leave the Basel-based company at the end of September.

North American contract manufacturer Jubilant HollisterStier has appointed Ian Fuller as its new vice president of Operations.

Many life science companies generate large swathes of data.

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining...